Growth Metrics

Pulmonx (LUNG) EBITDA Margin (2019 - 2025)

Pulmonx (LUNG) reported EBITDA Margin of 66.76% for Q3 2025, down 14.0% year-over-year from 77.63% in Q3 2024, and down 8.07% on a QoQ basis from 61.78% in Q2 2025.

Pulmonx (LUNG) has 7 years of EBITDA Margin data on file, last reported at 66.76% in Q3 2025.

  • Quarterly EBITDA Margin fell 14.0% year-over-year to 66.76% in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 62.24% (up 903.0% YoY) and the FY2024 annual result came in at 67.93%, up 1911.0% from the prior year.
  • EBITDA Margin retreated to 66.76% in Q3 2025 per LUNG's latest filing, from 61.78% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 57.21% in Q4 2024 and bottomed at 149.25% in Q1 2022.
  • The 5-year median for EBITDA Margin is 84.4% (2023), against an average of 88.67%.
  • Peak annual rise in EBITDA Margin reached 21958 bps in 2021, while the deepest fall reached 5843 bps in 2021.
  • Tracing LUNG's EBITDA Margin over 5 years: stood at 93.65% in 2021, then grew by 2 bps to 91.44% in 2022, then increased by 25 bps to 68.43% in 2023, then rose by 16 bps to 57.21% in 2024, then dropped by 17 bps to 66.76% in 2025.
  • Per Business Quant, the three latest LUNG EBITDA Margin figures stand at 66.76% (Q3 2025), 61.78% (Q2 2025), and 63.71% (Q1 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 Pulmonx 67.30 Mn -2.45 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 -66.76%
Jun 30, 2025 -61.78%
Mar 31, 2025 -63.71%
Dec 31, 2024 -57.21%
Sep 30, 2024 -66.63%
Jun 30, 2024 -73.69%
Mar 31, 2024 -76.51%
Dec 31, 2023 -68.43%
Sep 30, 2023 -84.40%
Jun 30, 2023 -93.40%
Mar 31, 2023 -107.43%
Dec 31, 2022 -91.44%
Sep 30, 2022 -104.67%
Jun 30, 2022 -105.56%
Mar 31, 2022 -149.25%
Dec 31, 2021 -93.65%
Sep 30, 2021 -76.28%
Jun 30, 2021 -105.65%
Mar 31, 2021 -138.33%
Dec 31, 2020 -94.20%
Sep 30, 2020 -36.06%
Jun 30, 2020 -325.24%
Mar 31, 2020 -79.90%
Dec 31, 2019 -46.03%
Sep 30, 2019 -46.76%